Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Gandara

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
American Journal of Hematology|November 1, 1989
Post-transfusion purpura and isoimmune neonatal thrombocytopenia in the same familyE Cobos, D R Gandara, L J Geier, et al.
Cancer|December 1, 1984
Hepatic dysfunction and jaundice following high-dose cytosine arabinosideC B George, R P Mansour, J Redmond, et al.
Seminars in Oncology|July 7, 2001
Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non--small cell lung cancer: focus on docetaxelD R Gandara, P N Lara, Z Goldberg, et al.
Cancer|July 1, 1984
Morbidity in long-term survivors of small cell carcinoma of the lungS A Volk, R F Mansour, D R Gandara, et al.
Oncology (Williston Park, N.Y.)|September 12, 2000
Evolution of combined modality therapy for stage III non-small-cell lung cancerD R Gandara, M Edelman, P Lara, et al.
The Annals of Thoracic Surgery|May 1, 1996
Multimodality therapy in stage III non-small cell lung cancerM J Edelman, D R Gandara, M Roach, et al.
Oncology (Williston Park, N.Y.)|August 29, 2000
Gemcitabine/carboplatin combination regimens: importance of dose scheduleD R Gandara, D H Lau, P N Lara, et al.
Seminars in Oncology|February 1, 1991
Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicityD R Gandara, E A Perez, V Weibe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase I study of high-dose cisplatin, ifosfamide, and etoposideE A Perez, P C Sowray, S L Gardner, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1997
Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: a pilot studyD H Lau, J K Ryu, D R Gandara, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
American Journal of Hematology|November 1, 1989
Post-transfusion purpura and isoimmune neonatal thrombocytopenia in the same familyE Cobos, D R Gandara, L J Geier, et al.
Cancer|December 1, 1984
Hepatic dysfunction and jaundice following high-dose cytosine arabinosideC B George, R P Mansour, J Redmond, et al.
Seminars in Oncology|July 7, 2001
Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non--small cell lung cancer: focus on docetaxelD R Gandara, P N Lara, Z Goldberg, et al.
Cancer|July 1, 1984
Morbidity in long-term survivors of small cell carcinoma of the lungS A Volk, R F Mansour, D R Gandara, et al.
Oncology (Williston Park, N.Y.)|September 12, 2000
Evolution of combined modality therapy for stage III non-small-cell lung cancerD R Gandara, M Edelman, P Lara, et al.
The Annals of Thoracic Surgery|May 1, 1996
Multimodality therapy in stage III non-small cell lung cancerM J Edelman, D R Gandara, M Roach, et al.
Oncology (Williston Park, N.Y.)|August 29, 2000
Gemcitabine/carboplatin combination regimens: importance of dose scheduleD R Gandara, D H Lau, P N Lara, et al.
Seminars in Oncology|February 1, 1991
Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicityD R Gandara, E A Perez, V Weibe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Phase I study of high-dose cisplatin, ifosfamide, and etoposideE A Perez, P C Sowray, S L Gardner, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1997
Concurrent carboplatin, etoposide and thoracic radiation for poor-risk stage III non-small-cell lung carcinoma: a pilot studyD H Lau, J K Ryu, D R Gandara, et al.
Pageof 9